H.R.T. Hormone Replacement Therapy – CBC News – HRT class action case on breast cancer OK’d
However, the lawsuit argues that the 2002 Women’s Health Initiative Study by the United States National Institutes of Health concluded there was a connection between hormone therapy and an increase in breast cancer.
After the study, use of the therapy plummeted and so did breast cancer rates, said David Klein, a lawyer representing the women.
Klein noted the company has been sued on similar grounds in the United States, leading to settlements in more than 3,300 cases.
Pfizer recently set aside $772 million to resolve the remaining claims, he noted.
“The drug is the same, no matter which side of the border it is sold on. The harm is the same. It is time for the defendants to also compensate injured Canadian women.”
